MedPath

Effect of Vitamin C on Premenstrual Syndrome

Phase 3
Conditions
Premenstrual Syndrome.
Premenstrual tension syndrome
N94.3
Registration Number
IRCT20240514061801N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
80
Inclusion Criteria

Students must live in the dormitory
Students should be willing to participate in the study
Students must be single
Students must be between 18-40 years old
Students should have a normal BMI (18/5-24/9)
Students must have regular menstruation (cycle duration 24-38 days)
Students' menstrual cycle should be 4-8 days
Premenstrual syndrome should be confirmed through a questionnaire derived from DSM V and a daily symptom record form for two consecutive months
Students should not use tobacco, alcohol and addictive substances

Exclusion Criteria

Students should not suffer from physical diseases such as diabetes, anemia, hypothyroidism, malnutrition, Cushing's syndrome, hyperprolactinemia
Students do not have a known mental illness
Students should not use anti-depressant drugs, hormones, vitamins, herbal drugs, aspirin and warfarin, drugs related to thyroid disorders, drugs related to prolactin disorders in the last three months
Surgery has not been done in the last six months
Unfortunate incidents such as the death of relatives have not occurred in the last six months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath